ICD-10-CM Billable Code

M08.24

Juvenile rheumatoid arthritis with systemic onset, hand

Clinical Classification Guidelines

Medical Intelligence & Overview

Juvenile rheumatoid arthritis (JRA), also known as juvenile idiopathic arthritis, is a chronic autoimmune disease that primarily affects children. The subtype with systemic onset (M08.24) involves widespread inflammation impacting not only the joints but also other organs and systems in the body. When this condition involves the hand, it raises concerns about joint pain, swelling, and potential long-term joint damage. Understanding this condition can help caregivers and patients recognize symptoms early and seek appropriate care.

Causes & Symptoms

Clinical Causes: The precise cause of juvenile rheumatoid arthritis with systemic onset is unknown. It involves an abnormal immune response where the body's immune system mistakenly attacks its own tissues. Genetic factors may play a role, with a predisposition linked to certain genes within the immune system. Environmental triggers, such as infections, might contribute to disease onset, but no specific infectious agent is directly responsible. Hormonal factors and other unidentified environmental influences may also be involved in the disease's development.

Key Symptoms: Persistent fever that often spikes in the late afternoon or evening. Howling joint pain, swelling, and warmth, particularly affecting the small joints of the hands and wrists. Skin rashes that may appear as pink or salmon-colored patches, sometimes with a lacy appearance. Fatigue, loss of appetite, and general malaise. Swelling and tenderness in the affected joints, leading to decreased mobility. May experience symptoms in other organs, such as the heart, lungs, liver, or spleen, leading to systemic issues. Limping or difficulty using the hands due to joint pain and swelling, especially in the fingers and wrists.

Diagnostic & Treatment

Diagnosis Path: Medical history review focusing on the duration and pattern of symptoms. Physical examination to evaluate joint swelling, warmth, and range of motion. Blood tests to identify inflammation markers (e.g., elevated ESR or CRP), anemia, and other autoimmune indicators such as antinuclear antibodies (ANA). Imaging studies like X-rays, ultrasound, or MRI scans to assess joint damage or inflammation. Exclusion of other conditions that may mimic juvenile rheumatoid arthritis, such as infections or other autoimmune diseases.

Treatment Protocols: Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce inflammation and relieve pain. Corticosteroids, such as prednisone, for managing severe disease flares. Disease-modifying antirheumatic drugs (DMARDs) like methotrexate to slow disease progression. Biologic therapies targeting specific immune system components, including cytokines like TNF-alpha blockers. Physical and occupational therapy to maintain joint flexibility, strength, and function. Regular monitoring and follow-up with healthcare providers to adjust treatments as needed. Supportive care, including pain management, nutritional support, and addressing psychosocial impacts of chronic illness.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M08.24 a billable ICD-10 code?
Yes, M08.24 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M08.24?
Clinical documentation must specify the nature of Juvenile rheumatoid arthritis with systemic onset, hand and any associated comorbidities for accurate reporting.

Cite this Clinical Reference